473.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$475.89
Offen:
$478.93
24-Stunden-Volumen:
446.22K
Relative Volume:
0.21
Marktkapitalisierung:
$175.70B
Einnahmen:
$44.56B
Nettoeinkommen (Verlust:
$6.72B
KGV:
26.67
EPS:
17.7387
Netto-Cashflow:
$6.29B
1W Leistung:
-5.82%
1M Leistung:
-6.35%
6M Leistung:
-1.39%
1J Leistung:
-7.10%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
472.98 | 176.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
186.66 | 131.71B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
571.64 | 45.48B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.75 | 31.55B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
284.54 | 27.79B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Insider Sell: Michael Shafer Sells Shares of Thermo Fisher Scien - GuruFocus
Thermo Fisher opens new distribution centre in Ireland - Pharmafile
Mackenzie Financial Corp Acquires 62,790 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Nanobots Market Growing at 10.8% CAGR Through 2031 Driven - openPR.com
Laboratory Informatics Market Set to Witness Rapid Growth - openPR.com
EXCLUSIVE: President Donald Trump speaks 1-on-1 with Local 12 during Cincinnati visit - WKRC
President Trump makes multiple stops in Greater Cincinnati: Here's a recap - WLWT
See protests over Donald Trump's visits to Kentucky, Cincinnati - The Courier-Journal
WATCH LIVE: Trump touts economic agenda, campaigns against Rep. Massie in Kentucky - PBS
Where is Trump going in Cincinnati? What to know about the 2 locations - Cincinnati Enquirer
President Trump delivers remarks in Hebron, Ky. (LIVE) - FOX19 | Cincinnati
President Trump touts TrumpRx, pharmaceutical manufacturing push in Cincinnati visit - WCPO 9 Cincinnati
President Trump talks prescription prices, Iran war during Thermo Fisher visit - WLWT
U.S. President Donald Trump visits Thermo Fisher Scientific in Cincinnati - Reuters Connect
Trump talks prescription costs, Iran war at Thermo Fisher Scientific - Cincinnati CityBeat
President Trump Tours Pharmaceutical Company in Cincinnati, Ohio - C-SPAN
President Trump talks drug prices, war in Iran at Thermo Fisher Scientific in Reading - FOX19 | Cincinnati
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing - GuruFocus
WATCH LIVE: President Trump participates in a site visit at Thermo Fisher Scientific - WFMZ.com
WATCH LIVE: Trump visits pharmaceutical company in Cincinnati - Fox Business
A Look At Thermo Fisher Scientific (TMO) Valuation After New Cryo EM Center And Fungal Diagnostics Launch - Yahoo Finance
White House boasts $4T in new U.S. investment as Trump pushes America First - KATU
Heavy traffic expected in NKY, Cincinnati during Trump visit. What to know - The Courier-Journal
Thermo Fisher Scientific Inc. $TMO Shares Bought by Quadrant Capital Group LLC - MarketBeat
Capital International Investors Purchases 5,698 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cell Dissociation Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA • BD (Becton - openPR.com
Bank of Montreal Can Has $247.14 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Watch President Trump tour Thermo Fisher Scientific, a pharmaceutical and biotech company - FOX19 | Cincinnati
Is Thermo Fisher Scientific (TMO) Fairly Priced After Recent Share Price Weakness? - simplywall.st
President Trump to visit Greater Cincinnati, plans to highlight local businesses - WLWT
Protest planned near Trump's stop at suburban Cincinnati manufacturer - Cincinnati Enquirer
Trump Announces Multi-State Visit Including Thermo Fisher Unit Tour - scanx.trade
[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis) - GlobeNewswire Inc.
P/E Ratio Insights for Thermo Fisher Scientific - Benzinga
Legal & General Group Plc Boosts Stake in Thermo Fisher Scientific Inc. - National Today
Van ECK Associates Corp Acquires 337,008 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Microplate Systems Market Is Going to Boom |• Thermo Fisher Scientific • Agilent Technologies - openPR.com
Commentary: Those job numbers tell us that Trump's economy really stinks - Los Angeles Times
Thermo Fisher Scientific Inc. (TMO) Announces the Opening of Cryo-Electron Microscopy Drug Discovery Center in South San Francisco - Insider Monkey
Thermo Fisher CEO Casper sells $2m in stock - Investing.com
Plant Tissue Culture Market Detailed In New Research Report 2026 - openPR.com
What to know about the businesses Trump is visiting in Cincinnati - Cincinnati Enquirer
Thermo Fisher looks to shake up Bay Area biotech with 10-foot microscope - The Business Journals
President Trump visiting Cincinnati area this week. What to know - Cincinnati Enquirer
Goldman Sachs Cuts Price Target on Thermo Fisher Scientific to $650 From $710 - marketscreener.com
WINTON GROUP Ltd Grows Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by LGT Fund Management Co Ltd. - MarketBeat
Thermo Fisher stock forecast for 2030: $9B Clario deal and AI partnerships eyes $700 - Traders Union
Thermo Fisher Scientific opens new distribution centre in Meath - Silicon Republic
Thermo Fisher Scientific launches new test to help transplant patients receive anti-rejection medication sooner - SelectScience
President Donald Trump expected to make remarks in northern Kentucky Wednesday - LEX18
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):